Target intelligence / Profile preview

Gastrointestinal luminal gas bubbles and foam

Molecular classification
Physical target, Other
01

Overview

Gastrointestinal luminal gas bubbles and foam represent a physical target within the digestive tract consisting of trapped air and gases (such as nitrogen, hydrogen, and carbon dioxide) stabilized by mucus and food residues (StatPearls, 2023). This foam can cause abdominal distension, discomfort, and gas pains by preventing the easy passage of gas through the intestines (Mayo Clinic, 2023). Pharmacological intervention, primarily through anti-foaming agents like simethicone, targets the surface tension of these bubbles (PubChem, CID 6433516). By lowering surface tension, the drugs cause small, trapped bubbles to coalesce into larger ones, which are then more easily eliminated via belching or flatulence (NIH, 2022). This target is also significant in diagnostic procedures like endoscopy, where foam can obscure the view of the mucosal lining, often requiring the use of simethicone as a premedication to improve visibility (World Journal of Gastrointestinal Endoscopy, 2019).

Other names
Intestinal gasGastrointestinal foamTrapped gasAbdominal gasIntestinal bubblesLuminal foam
02

Mechanism of action

Anti-foaming agents act as surfactants to reduce the surface tension of gas bubbles within the gastrointestinal tract, causing them to coalesce into larger bubbles that are more easily expelled through belching or flatulence (StatPearls, 2023; PubChem, CID 6433516).

03

Biological functions

Gas transportDigestion byproductOther
04

Disease associations

FlatulenceBloatingFunctional dyspepsiaIrritable bowel syndromePostoperative gas painOther
05

Safety considerations

Interference with absorption of other medications (e.g., levothyroxine)Masking of underlying gastrointestinal disorders
06

Interacting drugs

Simethicone

1 more in the full profile.

07

Biomarkers

Abdominal girthFrequency of flatulenceEndoscopic foam score (e.g., McNally score)

Beyond the preview

Go deeper on Gastrointestinal luminal gas bubbles and foam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal luminal gas bubbles and foam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call